Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Depreciation & Amortization (CF) (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Depreciation & Amortization (CF) for 9 consecutive years, with $37.7 million as the latest value for Q1 2026.

  • For Q1 2026, Depreciation & Amortization (CF) rose 8.21% year-over-year to $37.7 million; the TTM value through Mar 2026 reached $143.2 million, down 22.46%, while the annual FY2025 figure was $140.3 million, 31.19% down from the prior year.
  • Depreciation & Amortization (CF) hit $37.7 million in Q1 2026 for Select Medical Holdings, up from $36.2 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $54.1 million in Q1 2024 and bottomed at $34.4 million in Q3 2025.
  • Average Depreciation & Amortization (CF) over 5 years is $46.8 million, with a median of $51.0 million recorded in 2022.
  • Year-over-year, Depreciation & Amortization (CF) plummeted 35.62% in 2025 and then grew 8.21% in 2026.
  • Select Medical Holdings' Depreciation & Amortization (CF) stood at $52.2 million in 2022, then grew by 3.33% to $54.0 million in 2023, then fell by 15.27% to $45.7 million in 2024, then dropped by 20.85% to $36.2 million in 2025, then rose by 4.04% to $37.7 million in 2026.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $37.7 million, $36.2 million, and $34.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.